EXCLUSIVE | Top 5 takeaways from USFDA Chief

Published by: Priyanka Deshpande

Byline: Ekta Batra

Dr. Robert Califf, the current head of the US Food and Drug Administration (FDA), in an exclusive interview with CNBC-TV18, revealed that, at the age of 72, he relies on four generic drugs that likely come from India.

Medium Brush Stroke

Marking his first interaction with the Indian media, he emphasised the crucial role India plays in the US generic drug supply chain. Here are top 5 takeaways from USFDA Chief:

India & Compliance

Data integrity in a lot of the Indian companies have come up to a standard. Top down management, cultural issues have improved.

#1

Substandard drugs

Recent issues in India has strengthened the idea that there should be one standard for all. There is no reason why there should be no digital access to the entire supply chain.

#2

Strategy in India

A mixture of announced & unannounced inspections is important. Will see more unannounced inspections in India.

#3

Securing the Supply Chain

Need the reliance that we have on China to be distributed all around the world. India will be a dominant part of planning the resilience of supply chains.

#4

India-US Relations

Relationship with India is long standing. India & US are powerful economies with strengths which match.

#5

For more webstories, click below